Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

A phase I study of the HDM2 antagonist SAR405838 combined with the MEK inhibitor pimasertib in patients with advanced solid tumours.

de Weger VA, de Jonge M, Langenberg MHG, Schellens JHM, Lolkema M, Varga A, Demers B, Thomas K, Hsu K, Tuffal G, Goodstal S, Macé S, Deutsch E.

Br J Cancer. 2019 Feb;120(3):286-293. doi: 10.1038/s41416-018-0355-8. Epub 2018 Dec 26.

PMID:
30585255
2.

First-in-human trial of the PI3Kβ-selective inhibitor SAR260301 in patients with advanced solid tumors.

Bédard PL, Davies MA, Kopetz S, Juric D, Shapiro GI, Luke JJ, Spreafico A, Wu B, Castell C, Gomez C, Cartot-Cotton S, Mazuir F, Dubar M, Micallef S, Demers B, Flaherty KT.

Cancer. 2018 Jan 15;124(2):315-324. doi: 10.1002/cncr.31044. Epub 2017 Oct 4.

3.

Cross calibration of two dual-energy X-ray densitometers and comparison of visceral adipose tissue measurements by iDXA and MRI.

Reinhardt M, Piaggi P, DeMers B, Trinidad C, Krakoff J.

Obesity (Silver Spring). 2017 Feb;25(2):332-337. doi: 10.1002/oby.21722. Epub 2016 Dec 21.

4.

An appeal for safe and appropriate imaging of children.

Swensen SJ, Duncan JR, Gibson R, Muething SE, LeBuhn R, Rexford J, Wagner C, Smith SR, DeMers B, Morin RL, Santa J, Homer CJ.

J Patient Saf. 2014 Sep;10(3):121-4. doi: 10.1097/PTS.0000000000000116. No abstract available.

PMID:
24988212
5.

Characterization of a large panel of patient-derived tumor xenografts representing the clinical heterogeneity of human colorectal cancer.

Julien S, Merino-Trigo A, Lacroix L, Pocard M, Goéré D, Mariani P, Landron S, Bigot L, Nemati F, Dartigues P, Weiswald LB, Lantuas D, Morgand L, Pham E, Gonin P, Dangles-Marie V, Job B, Dessen P, Bruno A, Pierré A, De Thé H, Soliman H, Nunes M, Lardier G, Calvet L, Demers B, Prévost G, Vrignaud P, Roman-Roman S, Duchamp O, Berthet C.

Clin Cancer Res. 2012 Oct 1;18(19):5314-28. doi: 10.1158/1078-0432.CCR-12-0372. Epub 2012 Jul 23.

6.

Early quantitative evaluation of a tumor vasculature disruptive agent AVE8062 using dynamic contrast-enhanced ultrasonography.

Lavisse S, Lejeune P, Rouffiac V, Elie N, Bribes E, Demers B, Vrignaud P, Bissery MC, Brulé A, Koscielny S, Péronneau P, Lassau N.

Invest Radiol. 2008 Feb;43(2):100-11. doi: 10.1097/RLI.0b013e3181577cfc.

PMID:
18197062
7.

[Translational research and Cancer Plan].

Vassal G, Borella L, Pierre A, Pamphile R, Bourrie B, Meflah K, Amalric F, Pauporte I, Caillot JL, Formstecher P, Demers B, Dumontet C, Grégoire M, Lethiec F, Boue AM, Tonelli D, Pilsudski R, Van Hijfte L, Cailliot C, Vrignaud P, Merlin JL, Oudet P, Arnoux PY, Lassale C.

Bull Cancer. 2007 Dec;94(12):1107-11. French.

8.

A secreted anti-activator, OspD1, and its chaperone, Spa15, are involved in the control of transcription by the type III secretion apparatus activity in Shigella flexneri.

Parsot C, Ageron E, Penno C, Mavris M, Jamoussi K, d'Hauteville H, Sansonetti P, Demers B.

Mol Microbiol. 2005 Jun;56(6):1627-35.

9.

The oximeter: boon or bane?

Demers B.

Chest. 2004 Nov;126(5):1399-401. No abstract available.

PMID:
15539700
10.

Drugs prescribed for patients shouldn't be taken by caregivers!

Demers B.

Chest. 2004 Oct;126(4):1012-3. No abstract available.

PMID:
15486352
11.

Regulation of transcription by the activity of the Shigella flexneri type III secretion apparatus.

Mavris M, Page AL, Tournebize R, Demers B, Sansonetti P, Parsot C.

Mol Microbiol. 2002 Mar;43(6):1543-53.

12.

Review of jerry menikoff, law and bioethics: an introduction.

Demers BN.

Am J Bioeth. 2002 Winter;2(1):67-8. doi: 10.1162/152651602317268032. No abstract available.

PMID:
22494040
13.

Perfluorocarbon fluid as a mediator of pulmonary barotrauma: a potential hazard of liquid ventilation.

Demers B.

Chest. 2000 Jan;117(1):8-10. Review. No abstract available.

PMID:
10631190
15.

Approaching the RSV season with a nursing plan of action.

Loveless R, Demers B, Linn WS.

Pediatr Nurs. 1995 Nov-Dec;21(6):suppl 1-4.

PMID:
8700601
16.

Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991.

Demers B, Simor AE, Vellend H, Schlievert PM, Byrne S, Jamieson F, Walmsley S, Low DE.

Clin Infect Dis. 1993 Jun;16(6):792-800; discussion 801-2.

PMID:
8329511
17.

Severe group A streptococcal disease--southern Ontario. Ontario Streptococcal Study Group.

Demers B, Low DE, Simor AE, Vellend H, Jamieson F, Walmsley S, Green K, Krishnan C.

Can Dis Wkly Rep. 1991 Aug 31;17(35):192-4. English, French. No abstract available.

PMID:
1934142
18.

Severe group A streptococcal disease--Toronto, Ontario.

Demers B, Simor AE, Vellend H, Low DE.

Can Dis Wkly Rep. 1990 Dec 22;16(51):259-60; discussion 260-1, 264. English, French. No abstract available.

PMID:
2073701
19.
20.

Risks of placing one-way valves in ventilator circuits.

Demers B, Mike RW.

Am J Dis Child. 1989 Apr;143(4):444. No abstract available.

PMID:
2929523
21.

Contraindications for chest physiotherapy.

Demers B.

Chest. 1986 Jun;89(6):902-3. No abstract available.

PMID:
3709262
22.

How nursing diagnosis helps focus your care. Beyond endocarditis.

Demers B.

RN. 1979 Dec;42(12):51-4. No abstract available.

PMID:
261459

Supplemental Content

Loading ...
Support Center